2018 Year in Review

2018 was a banner year for Asuragen as we continued to chart new territory with our assays and rapidly expand our AmplideX® and QuantideX® portfolios. In total, we nearly doubled the size of our assay portfolio, secured a number of key regulatory registrations, prepared and presented numerous scientific posters showcasing our innovative technologies at congresses around the world, and participated in panel discussions with experts from all facets of the healthcare industry.  See below for more information on all of our 2018 achievements and activities.

Thank you for your continued support of Asuragen and our journey to provide better answers for patients everywhere. We look forward to partnering with you in 2019!

View the product web pages:
AmplideX® PCR/CE DMPK Kit
AmplideX PCR/CE SMN1 Kit
QuantideX® NGS DNA Hotspot 21 Kit

View our Scientific Publications:

View our corporate workshop videos:

Back To